Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001325812-10-000025)

Filing Details

Accession Number:: 0001325812-10-000025
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-06-18 13:00:00
Reporting Period:: 2010-06-17

Filing Date:: 2010-06-18
Accepted Time:: 2010-06-18 17:03:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178670	Alnylam Pharmaceuticals Inc.	ALNY	Pharmaceutical Preparations (2834)	770602661

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1332911	L James Vincent	300 Third Street Cambridge MA 02142		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-06-17	1,333	$15.70	8,667	No	4	S	Direct
Common Stock	Disposition	2010-06-18	8,667	$15.16	0	No	4	S	Direct
Common Stock	Acquisiton	2010-06-18	12,100	$7.02	12,100	No	4	M	Direct
Common Stock	Disposition	2010-06-18	12,100	$15.19	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2010-06-18	12,100	$0.00	12,100	$7.02

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2015-07-12	No	4	M	Direct

Footnotes

The stock option vested as to one third of the shares on each of the first, second and third anniversaries of the grant date.